GENE ONLINE|News &
Opinion
Blog

2018-03-15| Technology

Stephen Hawking, Legendary Physicist and Cosmologist, Dies at 76

by GeneOnline
Share To

The legendary scientist, Stephen William Hawking (January 8, 1942 – March 14, 2018) has passed away at the age of 76 at his home town in Cambridge, England, on March 14, 2018.

By Joanne Shih

Stephen Hawking, an English theoretical physicist, cosmologist, and the author of A Brief History of Time and many other popular publications, spent his life time exploring the mysteries of the cosmos, time and black holes.

In 1963, Hawking was diagnosed with a rare early-onset slow-progressing form of motor neurone disease, amyotrophic lateral sclerosis (ALS), when he was 21. The disease caused Hawking loss of physical abilities and gradually paralyzed him over the years, doctors gave him a life expectancy of two years at that time. Nevertheless, Hawking was not discouraged by his physical disabilities, but carries on an extraordinarily meaningful life with his passion for science. With physical accessibility devices, Hawking was able to communicate with others and deliver significant scientific works.

Hawking was the pioneer in studying the universes and the first to establish a theory of cosmology described the theory of relativity and quantum mechanics. Hawking also had a renowned collaboration with Roger Penrose on gravitational singularity theorems explaining that black holes emit radiation, which often called Hawking radiation.

His scientific works were recognized by the Fellow of the Royal Society of Arts (FRSA), and the Pontifical Academy of Sciences. In 2009, Hawking also received the Presidential Medal of Freedom, the highest civilian award in the United States.

Reference
https://en.wikipedia.org/wiki/Stephen_Hawking

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
LATEST
Relmada Blames ‘Implausible Placebo Results’ on Depression Drug’s Failure Again
2022-12-07
Using Sound Waves to Sort Blood-Based Nanoparticles
2022-12-07
Summit Bets $5 Billion On Akeso’s Bispecific Antibody
2022-12-07
Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood
2022-12-07
Novartis’ Pluvicto Continues Winning Streak In Prostate Cancer Indication
2022-12-07
Algernon Wins FDA Orphan Drug Designation For Rare Lung Disease Candidate
2022-12-07
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
2023-01-09
JPM Annual Healthcare Meeting 2023
San Francisco, USA
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!